Recently, the No.6 Chinese Medicine Plant of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has made new achievements, and the exclusive variety Shunaoxin Dropping Pills has been granted three national invention patents, namely, A Composition and Its Pharmaceutical Preparation, the Application of a Composition in Preparing Drugs for Treating or Preventing Depression, and the Detection Method of Shunaoxin Dropping Pills, involving material basis, new use, gas phase characteristic spectrum detection method and so on. The approval of the patent will effectively enhance the protection of intellectual property rights of products, and will also provide stronger support for the marketing of Shunaoxin Dropping Pills.

 Shunaoxin Dripping Pill is exclusively produced by the No.6 Chinese Medincine Plant of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, which is made of Chuanxiong and Angelica sinensis and has the effects of regulating qi and promoting blood circulation, removing blood stasis and relieving pain. It is used for migraine caused by blood deficiency and blood stasis, with symptoms such as headache, dizziness, blurred vision, amnesia and insomnia.

The enterprise will closely focus on the development strategy and layout of Tianjin Pharmaceutical Holdings Co., Ltd. and Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, pay attention to the implementation of intellectual property strategic planning, carry out the patent layout of key varieties, and protect intellectual property throughout the product life cycle.